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Germinal Matrix Hemorrhage -Intraventricular hemorrhage (IVH) is a bleed 
of multifactorial etiology involving the highly vascular and delicate neuro-glial 
precursors in the developing brain. It poses a challenging complication in preterm 
newborns. This chapter provides a focused discussion on the current concepts in 
pathogenesis, management, and complications of IVH. The radiological findings at 
diagnosis and follow-up and the cytological features of CSF will be valuable to both 
frontline and diagnostic healthcare providers. The chapter also reviews the ongoing 
scientific development in the field. The authors believe that this chapter will be a 
valuable tool for all healthcare providers (students, physicians, and in nursing care) 
in managing this challenging condition.
Keywords: Germinal matrix hemorrhage, intraventricular hemorrhage, IVH, 
intracranial hemorrhage, superficial siderosis, central nervous system, cerebrospinal 
fluid, genetic alterations, cranial ultrasound, preterm complications, low birth weight
1. Introduction
The germinal matrix (GM) is a specialized layer of glial and neuronal precursor 
cells in the periventricular region of the brain with high metabolic activity, which 
is strongly dependent on its rich vascularity and rapid angiogenesis [1]. The dense 
and fragile vasculature makes GM selectively vulnerable to hemorrhage. Germinal 
matrix – intraventricular hemorrhage (GM-IVH) is the most common type of intra-
cranial hemorrhage in preterm infants. A combination of increased perinatal stress, 
poor cerebral autoregulation, and inherent fragility of the nascent vessels in the 
germinal matrix increases the likelihood of the development of GM-IVH in preterm 
infants. Also, there is evidence of occurrence in-utero and among full-term infants, 
however, such cases are rare [2]. The germinal matrix disappears by 36–37 weeks of 
gestation (wg), so GM-IVH is more likely in preterm infants than full term.
The global incidence of GM-IVH among preterm infants ranges from 14.7% 
to 44.7%, with variations across gestational age groups, countries, and antenatal 
and neonatal care [3]. The widespread use of cranial ultrasonography since the 
early 1980s, increasing knowledge of risk factors, antenatal steroid usage, and 
improved intensive care have improved incidence, survival, and morbidity of GMH 
[4]. However, GMH continues to remain a significant healthcare issue in preterm 




2. Germinal matrix- intraventricular hemorrhage
2.1 Pathogenesis
Developmentally, GM is located in the ganglionic eminence of the brain and 
is most pronounced in the caudate nucleus. The thickness and density of GM 
vasculature are higher than other brain areas and begin to decrease after 24 weeks 
of gestation (wg) and almost disappear at 36–37 wg with increasing fetal matu-
rity [1, 5]. A significant bleed in the highly vascular GM breaks the associated 
ependyma to involve the lateral cerebral ventricle constituting intraventricular 
hemorrhage (IVH) [6, 7]. The incidence of GMH-IVH increases with decreasing 
gestation age at birth in preterm infants [8–10].
The pathogenesis of GM-IVH is complex and heterogeneous. The blood–brain 
barrier (BBB) associated with GM vasculature is distinct from the remaining areas 
in the brain due to diminished: 1) pericytes, 2) fibronectin in the basal lamina, and 
3) GFAP (glial fibrillary acidic protein) in astrocyte endfeet (Figure 1). The paucity 
of three essential components of the BBB leads to the altered structural integrity 
of GM vasculature. First, pericytes play an essential role in BBB development, 
especially in early angiogenesis, extracellular matrix production, and endothelial 
maturation [11]. The paucity of pericytes in GM is associated with diminished levels 
of TGF-β [12] and predisposition to hemorrhage in dilatated blood vessels in experi-
mental models [13]. Second, fibronectin, a high molecular weight glycoprotein, is 
selectively deficient in the GM basement membrane [14]. Fibronectin polymerizes 
to provide structural integrity to blood vessels and is dependent on TGF-β for its 
upregulation. While other basement membrane components, including Collagen I, 
II, IV, laminin, and perlecan, are similar to other components in the human brain 
[14, 15]. Third, astrocytes provide vascular integrity by sheathing the predomi-
nance of the BBB with their GFAP rich extensions (endfeet). Autopsy studies in 
premature infants show decreased GFAP expressing astrocyte endfeet in GM than 
Figure 1. 
Diagrammatic representation of the coronal section of a preterm brain to highlight the factors contributing to 
the labile structure of the blood brain barrier in the germinal matrix and pathogenesis of the GM-IVH.
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cerebral cortex and white matter [16]. These make the blood–brain barrier fragile 
and more susceptible to hemorrhage.
Microscopically the GM vasculature has been described as circular in coronal 
sections, compared to elongated and flat vessels in other areas of the brain, repre-
senting the immaturity of the vessels from rapid angiogenesis and high endothelial 
turnover [17]. In addition, immunofluorescence and electron microscopy have 
shown a paucity of pericytes in the GM vascular environment [12].
Finally, fluctuations in cerebral blood flow precipitate into hemorrhage in 
the delicate GM. In addition, defects in the hemostatic mechanisms expectantly 
promote hemorrhage [6, 7].
Germinal matrix cells being metabolically active precursor neuronal and glial 
cells in the early stages of maturation demand a specialized and rich blood supply. 
This requirement is met by accelerated angiogenesis dependent on high levels of 
vascular endothelial growth factors (VEGF) and angiopoietin-2 and low expres-
sion of TGF-β [1]. Also, the GM is in a state of relative hypoxia, a driving force for 
continuous angiogenesis [6, 7]. Intriguingly, this may explain the near absence 
of GM-IVH after over 3–5 days of birth irrespective of the duration of gestation. 
Likely, higher oxygenation following birth inhibits rapid angiogenesis. Thus, a 
labile combination of metabolically active immature/precursor cells with a rich 
but “structurally weak” vasculature provided a high-risk background for bleeding, 
especially with high-velocity cerebral blood flow.
Among many factors associated with alteration in cerebral blood flow, severe 
respiratory distress syndrome, patent ductus arteriosus, high central venous, and 
hypercarbia are most prominent. While autoregulation maintains constant cerebral 
blood flow, this mechanism is impaired in premature infants with lower birth 
weight. Thus, changes in blood volume or pressure are more likely to affect cerebral 
circulation. Interestingly, the results of studies directly comparing impaired auto-
regulation with GMH-IVH have been mixed [18–20] and provide an opportunity for 
further research in this direction. As seen in pneumothorax and mechanical ventila-
tion (on high mean airway pressure mode), high central venous pressure stands out 
as a solid contender to contribute to IVH. This is also concordant with the venous 
nature of GM-IVH [21]. Interestingly, mechanical ventilation in synchronized and 
intermittent mandatory mode prevents higher velocity/turbulence of cerebral blood 
than fixed frequency/pressure modes.
Significant other risk factors affecting include prolonged labor, maternal 
chorioamnionitis, early-onset sepsis, development of respiratory distress, recurrent 
tracheal suctioning (supportive care especially during mechanical ventilation), 
and hypoxia. While most of these factors impact cerebral blood flow, infectious 
and hypoxic etiologies alter the GM microvasculature. The role of hypotension and 
rapid sodium bicarbonate infusion in the causation of IVH are inconclusive.
2.2 Diagnosis
Clinical manifestations of GM-IVH include asymptomatic to subtle alterations 
in consciousness, limb and eye movement, and changes in muscular tone following 
IVH. Further, severe cases may be associated with cardiorespiratory distress and 
progression to seizures, hypotonia, or decerebrate posturing [22].
Cranial ultrasound (CUS) remains the most practical and well-utilized approach 
for diagnosing and monitoring GM-IVH evolution. Newer ultrasound devices with 
high-frequency transducers allow for enhanced evaluation. Epidemiologically, 
surviving infants born preterm at 24 weeks have a higher incidence (10–25%) 
of high-grade GM-IVH (grade 3–4) as compared to preterm infants born after 
28 weeks (<5%) [8–10]. Almost half the cases of postnatal GM-IVH present on the 
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first day of life, with nearly ~90% presenting within the first 72 hours. As discussed 
in pathogenesis, increased oxygenation after birth likely stabilizes the GM-BBB and 
makes infants almost resistant to GM-IVH after the first week of life irrespective 
of gestational age [23]. Therefore, regular CUS schedules have been recommended 
based on the gestational age at birth and when otherwise clinically indicated [24].
Traditionally, GM-IVH had been graded into four categories based on the extent 
of hemorrhage beginning in the venule that drains into the subependymal collec-
tor veins: grade-1 representing subependymal hemorrhage; grade-2 with limited 
(filling <50% of normal-sized ventricles) IVH; and grade-3 with extensive IVH. 
Grade-4 was defined as IVH with parenchymal extension [25]. However, the latter 
was better identified as parenchymal venous infarction (PVI), though parenchymal 
extension does also rarely occurs [26]. Interestingly, PVI may occur in all, includ-
ing lower grades (1 and 2) of GM-IVH [22]. Since PVI is associated with long-term 
complications and risk of mortality (based on location and extent), a three-stage 
grading with an additional description of PVI has been recommended [22, 24] 
(Figure 2). In addition, early GMH may alter local neuronal and glial precursors 
with neurological consequences, description of location of bleed in addition to 
grade is suggested.
On CUS, grade 1 GMH is subependymal, hyperechoic, and globular. Evaluation 
in both coronal and sagittal planes helps distinguish a small GMH from choroid 
plexus on an initial diagnostic scan. Also, echogenicity at the caudothalamic groove 
(usual site for GMH) in the late neonatal period likely represents hyperechoic 
germinolysis and not late GMH [27]. Distinguishing pure subependymal bleed from 
IVH may be challenging on CUS. Indirect signs of hyperechoic ependymal changes, 
which usually occur 2 to 4 weeks after IVH, and insonation through mastoid fon-
tanelle are helpful in this distinction [24] and aid prognostication and counseling. 
Figure 2. 
GMH/IVH: Origin and grading. GMH starts in a venule that drains into lateral subependymal collector veins; 
it extends into white matter by virtue of venous compression and infarction; bottom row: T2-weighted MRI of 
GMH with limited IVH and limited venous infarct. (Derived from Parodi et al. [24]).
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Clot changes overtime should also be recorded. A subacute clot or clot remnants 
early after birth may represent an antenatal hemorrhage.
PVI typically is identified as a triangular echo density in the periventricular 
white matter adjacent to the GMH. The infarct may not touch the GMH initially and 
may or may extend into the GMH depending on severity. Infarcts eventually evolve 
into cavitary lesions, and porencephaly ensues in 1–2 months [24]. This cavitation 
is asymmetric, unilateral, and permanent in contrast to cysts of periventricular 
leukomalacia (symmetric, bilateral, and transient) [22].
A quarter of infants with GM-IVH develop posthemorrhagic ventricular dilata-
tion (PHVD) due to imbalanced production and resorption of CSF. This dilatation 
occurs a few days to weeks after IVH and is followed by subsequent regression [28]. 
PHVD is more common in higher grades but can occur in all cases with IVH. Thus, 
serial CUS is recommended in IVH cases until term-equivalent age. While a subset 
of cases resolves spontaneously, balancing the complications of compression versus 
those of surgical management (tapping, shunt) remains a challenge [29]. PVHD, as 
expected, is associated with a poor neurological outcome in the long term.
2.3 Genetic factors in GM-IVH
Thrombophilic genotype is frequently associated with a subset of severe 
GM-IVH patients with atypical clinical presentation. The atypical presentation 
includes periventricular hemorrhagic infarction presenting within 6 hours of birth 
or after four days of birth, in the absence of secondary inciting factors like sepsis. 
Factor V Leiden mutation was the most common genetic alteration, frequently with 
mothers being carriers. Prothrombin mutations and polymorphism of the MTHFR 
gene were also reported [30]. Previous studies have shown an association of a 
thrombophilic profile with early grade 1–2 GMH [31, 32]. Polymorphism of TNF-α 
has been associated with an increased risk of GMH-IVH [33]. Of interest, the same 
study showed an association of polymorphism in TGF-β with a fatal outcome but 
not with IVH.
Mutations of the COL4A1 gene, coding for type IV collagen α-chain-1, have 
rarely been reported in a subset of preterm IVH [30, 34]. A pair of dizygotic twins 
showed a heterozygous duplication at exon 4 of the highly conserved and ubiqui-
tous COL4A1. Interestingly, the mother and maternal grandmother of the twins 
were heterozygous carriers and were asymptomatic. Also, the study evaluated 39 
other cases of preterm IVH and detected no mutations in COL4A1, indicating its 
rarity [34]. Previous studies have revealed no alteration in type IV collagen compo-
nents in the basement membrane in GM [14, 15].
Experimental models have shown tropomyosin receptor kinase B (TrkB) to 
influence the inflammatory status in the microenvironment following GMH by 
influencing the phosphatidylinositol-3-kinases (PI3K)/protein kinase B (Akt)/
forkhead box protein O1 (FoxO1) pathway [35].
Overall, genetic alteration in components of vascular structure, coagula-
tion mechanism, and inflammatory pathways have been described in a subset of 
GM-IVH. The authors believe that recent progress in inflammation and growing 
knowledge of inflammasome complex may be employed towards further research in 
this direction.
2.4 Prevention
Our understanding of IVH due to a structurally labile and immature vascula-
ture in the germinal matrix and alterations in cerebral blood flow in premature 
infants forms the focus of most strategies to prevent GM-IVH. In principle, delay of 
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preterm birth relies on decreasing GM vascular density with advanced gestational 
age. Moreover, high postnatal oxygen levels in the infant mediate the stabilization 
of the GM blood vasculature and ensure freedom from IVH in 3–5 days after birth, 
highlighting the critical importance of timeliness in management and prevention.
2.4.1 Specific strategies for prevention
Steroids (glucocorticoids) like dexamethasone and betamethasone are admin-
istered to pregnant women in premature labor under 34 wg. Glucocorticoids cause 
a selective inhibition of blood vessels in the GM- BBB that lack adequate pericyte 
coverage, inhibit angiogenesis, and subsequently stabilize vasculature [12, 14, 36]. 
In addition, prenatal corticosteroid assists in development lungs surfactant and 
protect against respiratory distress syndrome. The latter effect also prevents tur-
bulent cerebral blood flow. Prenatal corticosteroid usage is one of the rare factors 
that has consistently been associated with a reduction in occurrence and severity 
of IVH [37, 38].
Indomethacin is a non-selective cyclooxygenase (COX) inhibitor and reduces 
severe IVH, especially in males [39, 40]. Indomethacin is employed for closure of 
patent ductus arteriosus that in turn prevents altered cerebral blood flow. It also 
suppresses angiogenesis by COX-2 inhibition [1]. Although indomethacin can 
decrease IVH in the short term, its usage is not associated with reducing long-term 
neurological complications such as cerebral palsy, deafness, and blindness [41–43]. 
Hence, indomethacin has limited acceptance and is based on regional preferences.
Prenatal care and transport: It is recommended that pregnant mothers be 
given adequate antenatal care and those in preterm labor be transported (while 
pregnant) to tertiary care units better equipped to manage both mother and child. 
Transportation of extremely premature infants has long been associated with the 
increased occurrence and severe IVH [44].
It is beneficial to note that antenatal phenobarbital and magnesium, vitamin-K, 
and fresh frozen plasma did not influence the occurrence of IVH [45–49].
Intriguing preclinical studies show time-sensitive windows for therapeutic 
pharmacological targeting of the GM “weakened” BBB by altering the integrin-β8 
and TGF-β pathways [50].
2.5 Management
Currently, there is a paucity of active treatment strategies for the management of 
established GM-IVH. Maintaining blood pressure levels and respiratory status, with 
judicious use of IV fluids, blood transfusions, and respiratory support (if needed), 
might prevent the progression of hemorrhage. Electroencephalogram (EEG) 
monitoring should be done in the presence of seizures [3]. Apart from supportive 
treatment, emphasis is laid on the preservation of cerebral perfusion and the 
prevention of complications. Monitoring twice weekly with CUS for four weeks (or 
similar) and then weekly till term equivalent age recommended to evaluate GMH 
and post hemorrhage hydrocephalus (PHH).
2.5.1 Post-natal effective nursing care
Multiple trials and observational studies have focused on the relative head 
position of premature infants soon after birth in relation to IVH. These positional 
strategies focus mainly on maintaining adequate cerebral blood flow.
While previous studies on the effect on neutral head position found no signifi-
cant association with the occurrence of IVH [51], these studies were also limited 
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by small sample size [52]. More recently, efficient, supportive nursing intervention 
in premature infants during the first 72 hours of birth has been associated with 
decreased incidence and progression of GM-IVH [53]. This four-pronged approach 
includes midline head position, head elevation of the incubator, and slow vascular 
flushing/withdrawal of blood, and sudden elevation of the legs. First, the head 
in midline position ensures adequate venous drainage. Head rotation impedes 
jugular venous outflow on the ipsilateral side and may cause congestion, relative 
hypoxia and eventually aid GMH [54]. Second, incubator head lift (15–30 degrees) 
enhances gravitational cerebral venous drainage [55]. Third, sudden elevation 
of legs, as in to change diapers, may result in increased venous return, increase 
cardiac preload, thereby altering cerebral perfusion. Finally, avoiding rapid (last-
ing <30 seconds) vascular flushing/blood collection can avoid a transient though 
significant alteration in cerebral blood flow [56]. The effect of the intervention was 
stronger in infants born before 27 wg [53]. While previous studies on the effect on 
neutral head position found no significant association with the occurrence of IVH 
[51], these studies were limited by small sample size [52]. A more recent meta-anal-
ysis showed the limited utility of supine midline head position for the prevention 
of GM-IVH. However, midline head position with an elevation of incubator head 
was associated with lower mortality [57]. Overall, concomitant intervention with 
neutral head position, the elevation of incubator head, and avoidance of sudden 
leg elevation and sudden vascular volumetric changes provide evidence for a better 
outcome.
2.6 Complications and potential treatment strategies
The survivors of severe GMH frequently develop post-hemorrhagic hydro-
cephalus (PHH). A subset of these cases requires surgical shunting, which is not 
without its complications, including infections, obstruction, and displacement 
[58]. In addition, the cerebroventricular dilatation causes physical pressure on the 
brain parenchyma and is associated with neurological impairment in the long term. 
Mechanism of PHH: Obstruction of the cerebral aqueduct, foramina of Luschka 
and Magendie, and subarachnoid outflow passages by blood clots/microthrombi 
may cause PHH. Historically, fibrinolytic therapy has not been successful in the 
management of PHH.
The tissue macrophage system responds to intracranial hemorrhage similar to 
other locations in the body. Red blood cells (RBCs) are phagocytosed by macro-
phages (erythrophages), and subsequently, hemoglobin is degraded. Iron mainly 
converts to coarse, irregular hemosiderin granules and porphyrin rings into bili-
rubin. In exceptional circumstances with closed compartments and lower oxygen 
tension, such as intracranial bleed, hematoidin, a crystalline, reduced biliverdin 
product may be formed. Post hemorrhagic components are frequently encountered 
on light microscopic evaluation of the cerebrospinal fluid (CSF), as early as 1–2 days 
after bleeding [59, 60]. In addition to the erythrophagocytosis, cellular components 
of the ventricular lining (ependymal cells and choroid plexus cells) and rarely, 
precursor germinal matrix cells (due to close proximity with disrupted ventricular 
lining) may be identified in CSF analysis [61–63].
Superficial siderosis (SS) is the deposition of hemosiderin in the subpial layers 
of CNS, resulting in sensorineural hearing loss and cerebellar ataxia in most adults 
cases [64]. Susceptibility weighted imaging (SWI), an MRI sequence, identified SS 
in the ependymal layer, brain stem, cerebellum with vermis, and Sylvian fissures. 
Interestingly the depth of SS correlated with the increasing grade of GM-IVH.  




A review of scientific literature shows the following current trends exploring the 
management of GMH and prevention of complications.
2.6.1 Iron in the manifestation of PHH
Experimental models have shown the role of iron (from red blood cells) to 
develop brain edema and acute ventricular dilatation [66]. As proof of principle, 
iron chelation with deferoxamine has showed reduced long term PHH after GMH 
in neonatal rats [67, 68]. Another group found biliverdin reductase to enhance 
CD36 expression in scavenging microglia and hematoma resolution through NOS/
TLR4 pathway [69]. Additionally, iron overload has been associated with increased 
aquaporin-4 expression [70]. However, diuretic treatment has not been found to be 
beneficial.
Along similar lines, “normal appearing” white matter in preterm infants with 
severe GM-IVH, at term equivalent age, showed paramagnetic (positive magnetic) 
susceptibility, likely due to diffusion of iron into the periventricular white matter 
[71]. This radiological finding may be employed as an innovative methodology 
for future research focusing on the spatial impact of iron deposition on long-term 
neurological consequences.
2.6.2 Role of inflammation and gliosis
Post GMH levels of pro-inflammatory markers like TNFα are elevated. In 
response to hemorrhage and associated tissue injury, resident microglia are acti-
vated in an inflammatory process [72–74]. Additional experimental models have 
shown microglial proliferation surrounding the clot with phosphorylated ERK. 
Minocycline and cannabinoid receptor-2 agonists have also shown promise to curb 
down inflammation [75]. CD200Fc inhibits inflammation following GMH likely by 
mediating CD200R1/Dok1 pathway [76]. IVH has been shown to cause a TLR4 and 
NF-κβ based inflammatory pathway mediated increase in CSF production in the 
choroid plexus. As a proof of principle, amelioration of these mediators was associ-
ated with control of CSF production and improvement in PHH [77]. The role of M2 
microglia stimulation through the PPARγ and CD36 scavenger receptor for short-
term resolution of hematoma has also shown promising results for further clinical 
evaluation [78]. NT-4 controls neuroinflammation by interacting with TrkB to 
induces PI3K-Akt pathway and inhibits downstream FoxO1 in experimental models 
[35]. These results promise potential for clinical utility in the management of PHH.
Extracellular matrix (ECM), especially components fibronectin and vitronec-
tin, are elevated post-GMH and are hypothesized to deposit (like microthrombi), 
potentially causing CSF obstruction [75, 79–81]. TGF-β may be induced by 
thrombin and promotes the production of ECM, especially TGF-β1 isoform whose 
levels have been elevated in studies after GMH. It’s inhibition has been associated 
with attenuated PHH and neurological decline [75, 81]. While GFAP expression 
is markedly increased in experimental IVH models, umbilical cord mesenchymal 
stem cell infusion has been associated with a decline in GFAP expression and 
subsequent PHH development [82]. The role of GFAP and astrocytes in gliosis post 
IVH requires further attention. More recently, astrogliosis was associated with 
redistribution of aquaporin-4 and altered CSF dynamics. Olomoucine controlled 
scarring and attenuated PHH by inhibition of cyclin-dependent kinase (CDK) 
[83]. Secukinumab, monoclonal IgG1κ targeting IL17a, is protective against reactive 
astrogliosis following GMH, partly by regulating IL-17RA/(C/EBPβ)/SIRT1  
pathways [84].
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2.6.3 Long term complications of low grade (grade 1: 2) GM-IVH
While neurological complications in survivors of high-grade GM-IVH are 
well documented, the impact of low-grade IVH currently continues to be better 
understood. Low-grade IVH was associated with moderate to severe neurodevel-
opmental impairment (NDI) and without association with cerebral palsy [85]. 
A case-controlled retrospective study using CUS found no significant impact of 
low-grade GM-IVH on neurological complications of cerebral palsy and neuro-
developmental delay evaluated during 18–30 months after birth [86]. Both these 
studies were limited in power and in analysis by more sensitive MR-based tech-
niques [87]. A more recent MR-based study has revealed microstructural impair-
ment of white matter related to neurodevelopmental impairment at 24 months 
in early GMH [88]. Similarly, magnetic resonance with 3D pseudo-continuous 
arterial spin-labeling (pCASL) perfusion sequence-based study has shown con-
sistently lower CBF in the posterior cortical and subcortical gray matter regions 
in preterm neonates with low grade IVH [89]. This regional susceptibility also 
requires correlation with long term studies. From a developmental perspective, 
neurological alterations are not incompatible with low-grade IVH. GMH may lead 
to altered myelination in the white matter since ganglionic eminence is the seat 
of oligodendroglial precursor cells that migrate to cerebral white matter areas 
to produce myelin later in the third trimester [90]. Besides, GM is involved in 
the development of GABAergic interneurons significant for high-level cognitive 
function [91].
3. Conclusion
Germinal matrix intraventricular hemorrhage is the most common intracranial 
hemorrhage in newborns, particularly preterm neonates. Improvements in obstet-
ric and neonatal care have led to increased survival of preterm infants. Despite 
extensive research and preventive measures, the incidence of associated complica-
tions and mortality remains high. The GM is highly susceptible to hemorrhage due 
to a combination of delicate vasculature and fluctuations of cerebral perfusion, 
uncontrolled by autoregulatory mechanisms. Genetic factors and coagulation 
disorders may factor in if present. Obstetric and neonatal clinicians should use the 
available knowledge to prevent the occurrence of and progressions of hemorrhages. 
Therapeutic options for the management of GM-IVH are predominantly limited to 
supportive care and monitoring. Shunts have proven to be effective in challenging 
cases of PHH. Current and ongoing improvement in the molecular understanding 
of GM-IVH and its complications using multi-omics investigations is essential to 
develop biomarkers and therapeutic strategies.
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